Application of UA-MHC H-2K(b)/SVYDFFVWL TRP2 tetramer-APC labeling in antigen-specific T cell detection

I. Research Background of Tumor-Associated Antigen-Specific T Cell Detection

Melanoma-associated antigen-specific CD8+ T cells play a central role in anti-tumor immune responses. Tyrosinase-related protein 2 (TRP2) is a differentiation antigen highly expressed in melanoma cells, belonging to the tumor-associated antigen family. Its derived antigen peptides can be presented by MHC class I molecules, eliciting specific T cell immune responses. Accurate identification and quantitative analysis of TRP2-specific CD8+ T cells are crucial for understanding melanoma immune mechanisms and evaluating immunotherapy efficacy. The establishment of major histocompatibility complex (MHC) tetramer technology provides a key technical means for directly visualizing and quantitatively analyzing such tumor-associated antigen-specific T cells.

II. Core Principles of MHC Tetramer Technology

The principle of MHC tetramer technology is based on the specific recognition between T cell receptors (TCR) and MHC-antigen peptide complexes. Biotinylated monomeric MHC-antigen peptide complexes are mixed with fluorescently labeled streptavidin in an optimized ratio. The four biotin-binding sites of streptavidin can simultaneously bind four MHC monomers, forming a stable tetramer structure. This tetramer structure significantly enhances the affinity for antigen-specific TCR binding, enabling stable labeling of antigen-specific CD8+ T cells. Combined with flow cytometry, labeled cells can be precisely characterized and quantified. Additionally, by co-staining with other surface markers, the phenotypic characteristics, differentiation states, and functional subsets of antigen-specific T cells can be deeply investigated. This technology has been widely used for detecting tumor-associated antigen-specific T cells in mouse tumor models.

III. Construction and Characteristics of H-2K(b)/SVYDFFVWL TRP2 Tetramer

The H-2K(b)/SVYDFFVWL TRP2 tetramer is a specific detection tool assembled from the mouse H-2K(b) MHC class I molecule and the SVYDFFVWL peptide derived from the melanoma-associated antigen TRP2. This tetramer is labeled with APC fluorescence, offering high sensitivity, specificity, and excellent photostability. The APC fluorophore has high quantum yield, suitable excitation wavelength, and is ideal for multicolor flow cytometry analysis. TRP2 is a melanocyte differentiation antigen, with low expression in normal melanocytes and significantly high expression in melanoma cells, making it an important target for melanoma immunotherapy. This tetramer can specifically recognize CD8+ T cells with TCRs that recognize the TRP2 antigen peptide, and is widely used for detecting and analyzing antigen-specific CD8+ T cells in mouse melanoma models.

IV. Applications in Melanoma Immune Monitoring

The H-2K(b)/SVYDFFVWL TRP2 tetramer plays a critical role in monitoring immune status in mouse melanoma models. Using melanoma cell lines expressing TRP2 antigen, such as B16-F10, researchers can establish tumor-bearing mouse models and use this tetramer to monitor the distribution, expansion dynamics, and functional maintenance of tumor-specific CD8+ T cells in peripheral blood, lymphoid organs, and tumor tissues. During tumor growth, this tetramer can dynamically detect frequency changes of TRP2-specific CD8+ T cells and analyze their correlation with tumor burden. In tumor tissues, this tetramer can be used to detect the proportion and spatial distribution of TRP2-specific T cells among tumor-infiltrating lymphocytes (TILs). By co-staining with immune inhibitory molecules such as PD-1, TIM-3, and LAG-3, the functional exhaustion state of antigen-specific T cells in the tumor microenvironment and its relationship with tumor progression can be evaluated.

V. Applications in Immunotherapy Efficacy Evaluation

Immune checkpoint blockade therapy has achieved significant progress in melanoma treatment. The H-2K(b)/SVYDFFVWL TRP2 tetramer provides a direct detection tool for evaluating the immune effects of these therapeutic strategies. In tumor-bearing mice receiving anti-PD-1, anti-CTLA-4, or combination therapies, this tetramer can dynamically monitor frequency changes of TRP2-specific CD8+ T cells and assess the extent of therapy-induced expansion of tumor-specific T cells. By co-staining with memory markers such as CD62L, CD127, and KLRG1, the differentiation states of effector memory T cells, central memory T cells, and exhausted T cells can be further analyzed. Co-staining with the proliferation marker Ki-67 can assess the in vivo proliferative activity of antigen-specific T cells. The correlation analysis of these parameter changes with tumor growth inhibition provides key data support for understanding therapeutic mechanisms and optimizing combination therapy strategies.

VI. Applications in Tumor Vaccine Development

Vaccines targeting tumor-associated antigens are an important direction in tumor immunotherapy. The H-2K(b)/SVYDFFVWL TRP2 tetramer provides a standardized tool for evaluating the immunogenicity of tumor vaccines. After vaccination with candidate vaccines containing TRP2 antigen peptides, this tetramer can be used to detect the frequency of SVYDFFVWL-specific CD8+ T cells in peripheral blood and lymphoid tissues, assessing the strength and persistence of vaccine-induced T cell responses. By comparing TRP2-specific T cell responses induced by different vaccine vectors, adjuvants, and immunization regimens, optimal immunization strategies can be screened, including peptide vaccines, DC vaccines, viral vector vaccines, and nucleic acid vaccines. This method can also be used to evaluate the correlation between vaccine-induced T cell responses and protective anti-tumor immunity, providing preclinical data support for the optimized design of tumor vaccines.

VII. Which Manufacturers Provide UA-MHC H-2K(b)/SVYDFFVWL TRP2 Tetramer-APC Labeled?

Nanjing UA-Bio Technology Co., Ltd. (UA-Bio) has independently developed the "UA-MHC H-2K(b)/SVYDFFVWL TRP2 Tetramer-APC Labelled", a high-performance MHC tetramer reagent specifically designed for the identification and sorting of antigen-specific CD8+ T cells. This product is based on the complex of mouse H-2K(b) MHC class I molecule and the SVYDFFVWL antigen peptide derived from the melanoma-associated antigen TRP2, labeled with APC fluorescence. It aims to accurately and efficiently identify and quantify TRP2-specific CD8+ T cells, providing a stable and reliable standardized tool for tumor immunotherapy, melanoma research, and vaccine development.

Nanjing UA-Bio Technology Co., Ltd. is always committed to providing cutting-edge, high-quality core reagents and tools for immunology, cell therapy, and innovative drug development. For detailed technical parameters, validation data, or specific application inquiries regarding the "UA-MHC H-2K(b)/SVYDFFVWL TRP2 Tetramer-APC Labelled" (Catalog No.: UA089065), please feel free to contact us.